GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO share price / stock price today is 91.39 PKR. Today volume traded in GLAXO is 155 K, price change is -0.32%, high price is 94.00 PKR, and low price is 90.00 PKR.
Return (%) | Absolute Return | ||||||
---|---|---|---|---|---|---|---|
1 Week | 1 Month | 3 Month | 6 Month | 1 Year | |||
Return | 2.685% | 21.03% | 26.966% | 10.843% | -17.144% |
Date | Announce Title | Attachments |
---|---|---|
2023-10-30 | Tranmission of Quarterly Report for the Period Ended September 30, 2023 | View PDF |
2023-10-24 | Financial Results for the Quarter Ended 30-09-2023 | |
2023-10-17 | Board Of Directors Meeting | View PDF |
2023-08-28 | Transmission of Quarterly Report for the Period Ended June 30, 2023 | View PDF |
2023-08-22 | GLAXO | GlaxoSmithKline Pakistan Limited Financial Results for the Half Year Ended June 30, 2023 | |
2023-08-15 | Board Meeting | View PDF |
2023-06-02 | Change of Company Secretary | View PDF |
2023-06-02 | Material informaiton | View PDF |
2023-05-30 | Material Information - Resignation of Company Secretary | View PDF |
2023-05-24 | Certified True Copy of Resolution passed by the Shareholders in the Annual General Meeting held on May 24, 2023 | View PDF |
2023-05-17 | Notice of Election of Directors | View PDF |
2023-05-03 | Transmission of Annual Report for the Year Ended December 31, 2022 | View PDF |
2023-05-03 | Notice of Annual General Meeting | View PDF |
2023-04-28 | Transmission of Quarterly Report for the Period Ended March 31, 2023 | View PDF |
2023-04-27 | Financial Results For The Quarter Ended March 31, 2023 | View PDF |
2023-04-20 | Board of Directors Meeting | View PDF |
2023-04-20 | Notice of Annual General Meeting - Prior Publication | View PDF |
2023-04-05 | RESCHEDULING OF AGM AND BOOK CLOSURE DATES | View PDF |
2023-03-27 | Approval of Extension in Time for Holding the Annual General Meeting | View PDF |
2023-03-17 | Applied for Extension for Holding AGM for the Year ended 2022-12-31 | View PDF |
2023-02-09 | Financial Results for the Year Ended December 31, 2022 | View PDF |
2023-02-02 | Board Meeting - 4th Quarter 2022 on 9 February 2023 | View PDF |
2022-11-24 | Notice of Corporate Briefing Session 2022 | View PDF |
2022-10-28 | Transmission of Quarterly Report for the Period Ended September 30, 2022 | View PDF |
2022-10-25 | Financial Results for the Quarter Ended September 30, 2022 | View PDF |
2022-10-18 | Board Meeting | View PDF |
2022-09-28 | Appointment of Non-Executive Director | View PDF |
2022-09-28 | Appointment of Non-Executive Director | View PDF |
2022-09-16 | GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information REVOKED | |
2022-09-16 | GLAXO | GlaxoSmithKline Pakistan Limited REVISED | |
2022-09-16 | GLAXO | GlaxoSmithKline Pakistan Limited - Panadol Information | |
2022-08-29 | Transmission of Quarterly Report for the Period Ended June 30, 2022 | View PDF |
2022-08-23 | Financial Results for the Quarter Ended June 30, 2022 | View PDF |
2022-08-16 | Board of Directors Meeting - August 23, 2022 | View PDF |
2022-08-12 | Appointment of Ms. Lai Kuen Goh - Chairperson and Non-Executive Director | View PDF |
2022-08-10 | Resignation of Mr. Dmytro Oliinyk from the Board of GlaxoSmithKline Pakistan Limited | View PDF |
2022-06-30 | Material Information - Resignation of Mark Dawson as Director w.e.f. 30 June 2022 | View PDF |
2022-06-08 | Material Information | View PDF |
2022-05-10 | Credit of Final Cash Dividend 2021 | View PDF |
2022-05-06 | PRIOR PUBLICAITON NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND | View PDF |
2022-05-06 | Transmission of Quarterly Report for the Period Ended March 31, 2022 | View PDF |
2022-04-26 | Financial Results for the Quarter Ended March 31, 2022 | View PDF |
2022-04-25 | Board Meeting In Progress | View PDF |
2022-04-25 | Certified True Copy of Resolution - Annual General Meeting | View PDF |
2022-04-18 | Board Meeting | View PDF |
2022-04-04 | Notice of Annual General Meeting | View PDF |
2022-04-04 | Transmission of Annual Report for the Year Ended 2021-12-31 | View PDF |
2022-03-30 | Prior Publication of AGM Notice for the year 2021 | View PDF |
2022-02-25 | Financial Results for the Year Ended December 31 2021 | View PDF |
2022-02-18 | BOARD OF DIRECTORS MEETING | View PDF |
2021-12-06 | Corporate Briefing Session | View PDF |
2021-10-29 | Transmission of Quarterly Report for the Period Ended September 30, 2021 | View PDF |
2021-10-25 | Financial Results for the Quarter Ended September 30, 2021 | View PDF |
2021-10-18 | Board of Directors Meeting | View PDF |
2021-09-17 | CONVERSION OF PHYSICAL SHARES INTO BOOK ENTRY FORM | View PDF |
2021-08-27 | Transmission of Quarterly Report for the Period Ended 2021-06-30 | View PDF |
2021-08-23 | Financial Results for the Quarter ended June 30, 2021 | View PDF |
2021-08-20 | Board Meeting Reschedule | View PDF |
2021-08-16 | Board of Directors Meeting | View PDF |
2021-06-01 | Appointment of Chief Financial Officer and Executive Director | View PDF |
2021-05-17 | CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 | View PDF |
2021-05-04 | PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND | View PDF |
2021-04-30 | Transmission of Quarterly Report for the Period Ended 2021-03-31 | View PDF |
2021-04-28 | Financial Results for the Quarter ended March 31, 2021 | View PDF |
2021-04-27 | CERTIFIED TRUE COPY OF RESOLUTION | View PDF |
2021-04-27 | MEETING IN PROGRESS | View PDF |
2021-04-20 | Board of Directors Meeting | View PDF |
2021-04-06 | Notice of Annual General Meeting | View PDF |
2021-04-06 | Notice of Annual General Meeting | View PDF |
2021-04-06 | Transmission of Annual Report for the Year Ended 2020-12-31 | View PDF |
2021-04-05 | PRIOR PUBLICATION NOTICE OF ANNUAL GENERAL MEETING | View PDF |
2021-03-31 | Material Information | View PDF |
2021-03-10 | Financial Results for the Year Ended December 31, 2020 | View PDF |
2021-03-09 | GLAXO | GlaxoSmithKline Pakistan Limited | |
2021-03-02 | Board of Directors Meeting | View PDF |
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
Ms. Erum Shakir Rahim | CEO |
---|---|
Ms. Lai Kuen Goh | Chairman |
Mr. Agha Salman Taimur | Company Secretary |
GLAXO (GlaxoSmithKline Pakistan Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. GLAXO Share Price / Stock Price is 91.39 PKR. You can also check; Share Price History, GLAXOPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.
Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.
© 2023 SARMAAYA.PK